- This event has passed.
Grand Rounds: Elizabeth Bayliss, MD & Cynthia Boyd, MD | Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMZE Pragmatic Cluster Randomized Trial
Please join us a special Grand Rounds co-hosted with the US Deprescribing Research Network (USDeN) on Thursday, May 19, from 12pm – 1pm ET. The US Deprescribing Research Network (USDeN) aims to advance research on optimizing medication use among older adults. Join the USDeN mailing list here to receive updates on upcoming events.
Elizabeth Bayliss, MD, of the IMPACT Health Care Systems (HCS) Core, and Cynthia Boyd, MD, US Deprescribing Research Network (USDeN) Co-Director, will discuss “Deprescribing Education vs Usual Care for Patients with Cognitive Impairment and Primary Care Clinicians: The OPTIMZE Pragmatic Cluster Randomized Trial.”
Date/Time: May 19, 2022 from 12pm – 1pm ET
Speakers:

Elizabeth Bayliss, MD
Senior Investigator, Institute for Health Research, Kaiser Permanente Colorado
Professor of Family Medicine, University of Colorado School of Medicine
IMPACT Health Care Systems (HCS) Core

Cynthia Boyd, MD
Director, Division of Geriatric Medicine and Gerontology
Professor of Medicine, Epidemiology and Health Policy and Management
Johns Hopkins University School of Medicine
Co-Director, US Deprescribing Research Network (USDeN)
Zoom Conferencing
Join from PC, Mac, iOS or Android: https://hebrewseniorlife.zoom.us/j/97344810673
Dial-In: +1 312 626 6799 (US Toll) or +1 470 250 9358 (US Toll)
Meeting ID: 973 4481 0673